Welcome to our dedicated page for TELYRX HOLDINGS news (Ticker: TELYF), a resource for investors and traders seeking the latest updates and insights on TELYRX HOLDINGS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect TELYRX HOLDINGS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of TELYRX HOLDINGS's position in the market.
TelyRx (TSX:TELY, OTCQX:TELYF), a technology-enabled healthcare and pharmacy services company, announced its subordinate voting shares now trade on the OTCQX Best Market in the United States under symbol TELYF.
The shares will continue trading on the TSX. According to TelyRx, OTCQX trading offers U.S. investors easier access in U.S. dollars and supports goals of improved market accessibility, liquidity, and long-term shareholder value.